Cancers Treated:
Specializing In:
- Complicated Gynecologic Surgery
- Robotic and Minimally Invasive Approaches to Gynecologic Surgery
Research Interests:
- Strategies for the prevention and treatment of ovarian cancer
- Novel immunological therapies for endometrial cancer
- Clinical trials in gynecologic oncology
Biography
I have been on the faculty at Roswell Park in the Department of Gynecologic Oncology since 2010. Originally from Buffalo, NY, I did my medical school and residency training in Obstetrics/Gynecology at the University at Buffalo School of Medicine and Biomedical Sciences. This was followed by three years of advanced fellowship training in gynecologic oncology at the University of Alabama at Birmingham, focusing on all aspects of gynecologic cancer care, including advanced and minimally invasive surgical techniques, chemotherapy, gynecologic cancer screening and surveillance, as well as basic science research focusing on cell death in ovarian cancer.
My areas of clinical interest include all cancers of the female reproductive system, including uterine, ovarian, cervical, vulvar, and vaginal cancer. As the Clinical Chief and Director of Minimally Invasive Surgery for the Department of Gynecologic Oncology, I have taken a leading role in developing and promoting the robotics program at Roswell Park. I have performed thousands of robotic surgeries to treat and stage gynecologic cancers, as well as complex benign conditions such as endometriosis. I have lectured regionally and nationally on robotic surgery and the ground-breaking benefits it provides for well-selected patients. I have also trained and proctored dozens of surgeons in robotic surgical techniques.
I am a Fellow of the American Congress of Obstetricians and Gynecologists, as well as an active member in numerous professional organizations, including NRG Oncology, the Society of Gynecologic Oncology, the Buffalo Gynecologic and Obstetric Society, and the American Society of Clinical Oncology. I am board certified in Obstetrics and Gynecology and Gynecologic Oncology and have co-authored over 50 publications, as well as numerous book chapters and abstracts. I am also passionate about training the next generation of physicians in WNY and have served as the fellowship program director for our gynecologic oncology fellowship program and the Associate Dean of Graduate Medical Education where I strive to enhance the training and educational experience of all physician learners at Roswell Park.
In addition to my work with patients at our main campus in Buffalo, I also see patients at our satellite locations in Amherst, Niagara Falls and at the Roswell Park Care Network location in Jamestown, NY on a regular basis.
Positions
Roswell Park Comprehensive Cancer Center
- Associate Professor of Oncology
- Associate Dean of Graduate Medical Education
- Associate Program Director, Gynecologic Oncology Fellowship Program
- Director of Minimally Invasive Surgery in Gynecology Oncology
- Clinical Chief of Gynecology – Department of Gynecologic Oncology
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
- Clinical Associate Professor, Department of Obstetrics & Gynecology
Background
Education and Training
- MD - State University of New York at Buffalo, Buffalo, NY
- BA - University of Rochester, Rochester, NY
Residency
- State University of New York at Buffalo, Buffalo, NY (Gynecology/Obstetrics)
Fellowship
- University of Alabama at Birmingham, Birmingham, AL (Gynecologic Oncology)
Board Certification
- Obstetrics & Gynecology, American Board of Obstetrics & Gynecology
- Gynecologic Oncology, American Board of Obstetrics & Gynecology
Honors & Awards
- Buffalo Spree Magazine's list of Top Doctors 2019, 2020, 2021, 2022, 2023
- CREOG National Faculty Award for excellence in resident education
- Alpha Omega Alpha Medical Honor Society
Featured on CancerTalk
Showing all3 of 18 CollapseView all
Publications
Lynam S, Dowling J, Hutton M, Wypij H, Odunsi SB, Lele SB, Zsiros E, Akers SN, Frederick PJ. Video-based counseling and point-of-contact testing improves genetic screening completion in an ovarian cancer patient population. Annual Meeting, Society of Gynecologic Oncology, Toronto, Ontario, Canada (Virtual Conference), March 2020.
Grzankowski KS, Szender JB, Lele SB, Odunsi K, Frederick PJ. Evaluation of metachronous breast and endometrial cancers pre- and post-routine adjuvant tamoxifen usage. Annual Meeting, Society of Gynecologic Oncology. San Diego, CA, March 2016.
Grzankowski KS, Szender JB, Lele SB, Odunsi K, Frederick PJ. Examination of the time interval between diagnoses in women with metachronous primary endometrial and colorectal cancers supporting universal Lynch testing. Annual Meeting, Society of Gynecologic Oncology. San Diego, CA, March 2016.
Szender JB, Grzankowski KS, Zsiros E, Odunsi K, Lele SB, Frederick PJ. Impact of residents and fellows on post-operative outcomes in gynecologic cancer patients: an analysis of the ACS-NSQIP database. Annual Meeting, Society of Gynecologic Oncology. San Diego, CA, March 2016.
Szender JB, Mayor PC, Odunsi K, Lele SB, Zsiros E, Frederick PJ. Evaluating the trend of minimally invasive surgery for cervical cancer: a NSQIP database analysis. Annual Meeting, Society of Gynecologic Oncology. San Diego, CA, March 2016.
Frederick PJ, Szender BS, Hussein AA, Kesterson JP, Barnabei V, Guru K. Surgical competency for robot-assisted hysterectomy: development and validation of a clinical assessment tool. Annual Meeting, Association of Professors of Gynecology and Obstetrics. New Orleans, LA, March 2016.
3Grzankowski KS, Szender JB, Lele SB, Odunsi KO, Frederick PJ. Limited training exposure in intraoperative radiotherapy may result in omission of its use in treating locally advanced gynecologic malignancies. Annual Meeting, Society of Gynecologic Oncology. Chicago, IL, March 2015.
Brightwell RM, Eng K, Lele SB, Odunsi KO, Frederick PJ. Lymphocyte nadir and reconstitution during chemotherapy predicts survival in ovarian cancer patients. Annual Meeting, Society of Gynecologic Oncology. Chicago, IL, March 2015.
Kolomeyevskaya N, Miller A, Hacker K, Riebandt G, Blum B, Odunsi K, Lele S, Frederick PJ. Oxaliplatin is a safe alternative therapeutic option in patients with recurrent gynecologic cancers following hypersensitivity reaction to carboplatin. Annual Meeting, Society of Gynecologic Oncology. Tampa Bay, FL, March 2014.
Akers SN, Khulpateea B, Groman A, Kesterson JP, Frederick PJ. Adjuvant treatment for uterine leiomyosarcoma. Annual Meeting, Society of Gynecologic Oncology. Austin, TX, March 2012.